Aussie investors no longer buying tech pipe dreams
Earnings season showed investors have stopped listening to idle talk of future growth from tech firms and are valuing those that can prove their value.
Stay updated with breaking news from Pro Medicus. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Earnings season showed investors have stopped listening to idle talk of future growth from tech firms and are valuing those that can prove their value.
Pro Medicus Limited (OTCMKTS:PMCUF – Get Rating) saw a significant increase in short interest in February. As of February 15th, there was short interest totalling 19,500 shares, an increase of 71.1% from the January 31st total of 11,400 shares. Based on an average trading volume of 300 shares, the short-interest ratio is currently 65.0 days. […]
No debt and a focus on innovation has allowed software medical imaging company, Pro Medicus, to expand globally, turning its founders into billionaires.
No debt and a focus on innovation has allowed software medical imaging company, Pro Medicus, to expand globally, turning its founders into billionaires.
No debt and a focus on innovation has allowed software medical imaging company, Pro Medicus, to expand globally, turning its founders into billionaires.